{"cmr":"fr-cm-kg/XPAR/FR0013183985","since":null,"total":27,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-10-16","event_type":"newswire_release","title":"GenSight Biologics Announces the Closing of its €1.0 ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261016616410/en/GenSight-Biologics-Announces-the-Closing-of-its-%E2%82%AC1.0-Million-Fundraising-Supported-by-Existing-Shareholders","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"MeyMeGd25RE6V5tdewCC40iiCdZAJHQICa4_a1GrEhKqHCsA1s1AZ5Ig_H6bspF-NUYv9KOt5IwA61OtZtw3AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-10-08","event_type":"newswire_release","title":"GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261007822305/en/GenSight-Biologics-Announces-a-Successful-%E2%82%AC1.0-Million-Fundraising-Supported-by-Existing-Shareholders","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8gNgeIAHSK5tpoSDeD0yQawgjyIJ0rz0Tx4cBi78oihvdVJEITJN58aJNCJyPvtfuDhju3Nv1GZifrYFsFGBDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-10-08","event_type":"newswire_release","title":"Gensight Biologics and the 15-20 National Hospital ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261007247351/en/Gensight-Biologics-and-the-15-20-National-Hospital-Announce-NEJM-Publication-on-GS030-Phase-12-Trial-Results-in-Late-Stage-Retinitis-Pigmentosa","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"l8BIfD23xKnolF6ifHxD4s87-HZzPGE0xUFDBKWM-gk1az3C-b68uSUuQ47Z7DVip2878yROu57mFlMSH5csDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-10-08","event_type":"newswire_release","title":"GenSight Biologics Reports Cash Position as of September ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261007442702/en/GenSight-Biologics-Reports-Cash-Position-as-of-September-30-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wfSQx3LYX_d6rFVEPz7g08A4IHEaea8rIs7pzzbtU4fCt_6C3_hdXJLFaFZH2wQXcA69WCpqSf1cNFP-0lD5Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-09-08","event_type":"newswire_release","title":"GenSight Biologics Provides September 2026 Business Updates","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260907527861/en/GenSight-Biologics-Provides-September-2026-Business-Updates","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-FlHunJT7agW6Idz_zp00OkaCdY13NBCsn5Xh4M2XaG7o6hvz06WwkesfzTzoHXFFBM7cEiUcOVUgsvJP88JAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-07-08","event_type":"newswire_release","title":"GenSight Biologics Reports Cash Position as of June 30, 2026, and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260708654201/en/GenSight-Biologics-Reports-Cash-Position-as-of-June-30-2026-and-Provides-Business-Updates","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"98TU7n4-Cz6BNKhjAjpQWqKILZ3w5ZnwN42_ZuSCtQAU4ZSW6Jjw5mn5ZeBI37l_27ub4gWhbR3GPuFAPDOwCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-05-28","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0746","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0746","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rnkBO4qD1rAz9YFthLKaevQWodcaBtyFu-ZRI-vOQ7BD5Sn70mIvFI4MTRz_HydHEdkg_oX8Zu_N3oImruoIAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-05-20","event_type":"newswire_release","title":"GenSight Biologics Announces the Results of its Combined General ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260520115142/en/GenSight-Biologics-Announces-the-Results-of-its-Combined-General-Meeting-of-May-19-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HVi6Ises_ZiE2VcDWA-RnZJsL2PX4Qc5xqKBFhlxcNjrLfXa4q6r3kKWCuZ420bqNq8_D6PDAU0I26AdTNOMAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-04-15","event_type":"prospectus","title":"DocumentEnregistrementUniversel [VISA]","reference":"D.26-0251","category":"VISA","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/D.26-0251","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DocumentEnregistrementUniversel; documents 2; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qyi6ROKv3HEm_qmqUZuuBijOFs9kx5GLTybaz4qMXlmSAdWF5KlH-ySIYhctirwfzuFkIngDxa8sY1SD8sSECw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-04-07","event_type":"newswire_release","title":"GenSight Biologics Reports Cash Position and Revenue from Early ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260407657670/en/GenSight-Biologics-Reports-Cash-Position-and-Revenue-from-Early-Access-Program-as-of-March-31-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dnRddxnyVF_EiCzoNQJuI4M80L5RQ1FDtmFllrJVud63IXY5TPef6bvojvBof7YGnAwIWW0D1_Elv7nF30foDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-03-17","event_type":"newswire_release","title":"GenSight Biologics Announces the Closing of its Nearly €1.7 Million Fundraising","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260317767973/en/GenSight-Biologics-Announces-the-Closing-of-its-Nearly-%E2%82%AC1.7-Million-Fundraising","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"tk-iVZPx5gDg7XXlNhpwmHTtKhQ9NwtRDt8hEU-xnYViudq5y8GyxiYojQUVpWhD_tzllJNiNCu5Tc2OnIAdBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-03-17","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0326","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0326","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xo5nL_avC4zm5w3NxsjPoaK7USrI_Tr4bwvRtDRkBAjpF6hvSasjTzZgld7uYBF9NL8Baj2_U2LpVp6kCY1RDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-03-10","event_type":"newswire_release","title":"GenSight Biologics Announces Successful Fundraising Worth ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260310176674/en/GenSight-Biologics-Announces-Successful-Fundraising-Worth-Nearly-%E2%82%AC1.7-Million","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"E1FnGPRUZcxIwBgb4h8Nl1ewL7MIE_ZE3WR8BGDrG_Cd55ZTHIA_VSeK8MWoLYmxoqpNxZQE9zJgHmBmypQNAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-03-09","event_type":"newswire_release","title":"GenSight Biologics Provides Updates about GS010/LUMEVOQ ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260308983403/en/GenSight-Biologics-Provides-Updates-about-GS010LUMEVOQ-Early-Access-Programs-and-the-Ongoing-REVISE-Study","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"x6U5x1Kre0qSfeLv0Y4Giw2TSpTzt2rDOZzLJ4vtqG4muAWan6dGPywRDf06wOzY3NtayYfaUdhgjGt-_jLYBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-03-09","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0275","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0275","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Sq42OT_kXaMzCto5jWArjfeVIJBQWFiCAE_VeaSvg9Q1D92v-4vAyqEAvwtvRdf7TbA0c0EMGhrdWmVANml6BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-01-28","event_type":"agm_egm","title":"GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260128489702/en/GenSight-Biologics-Announces-the-Results-of-its-Extraordinary-General-Meeting-of-January-28-2026","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yr0ADQysSxyP7Ut4dlF6yNfwMiSJTYlqPldzTADoq2kwJpdjcelg6MZ1SUIyfm60-R_fQkYziG9MuQCvog4PAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-01-07","event_type":"newswire_release","title":"GenSight Biologics Announces Closing of Fundraising Worth Nearly EUR 2.9 Million","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260107559643/en/GenSight-Biologics-Announces-Closing-of-Fundraising-Worth-Nearly-EUR-2.9-Million","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GcNjpN4nYU26PNRqzVOYgwNFN4m02QDO-huI6yViRV9McotDGwzrM1J242HxK9jjt4GfN_EniUfWUuyFfkFMCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2026-01-05","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0003","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0003","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gL8d18cMZlbtsRKT-z3XBN5TYPWvTOSLxaGtEVnBw5IGq9AZ2wCTQliN8V2MqQRwj1CHdL4DWLJsJSHlITikDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-12-22","event_type":"newswire_release","title":"GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251222028829/en/GenSight-Biologics-Announces-Regulatory-Authorization-for-Early-Access-Treatment-with-GS010LUMEVOQ-in-Israel","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jmfKtPNo_1TnqDEFjJzTRky8gc6KPONxJ0k_y-3r11q68TmZ29Fv88Z0-4IRiYeZ1C9edcoCtKaL0QJEepjCCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-12-21","event_type":"newswire_release","title":"GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251221464508/en/GenSight-Biologics-Announces-the-Granting-of-Compassionate-Use-Authorization-CUAAAC-for-GS010LUMEVOQ-in-France","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BnceTJtooVihBBbM72V-u9BwRlPHOaY2SnJzaiQgJFSLVMBHQg5C7YHgMRf8oAhrEcbErSSu12pnk9enWsDsCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-12-02","event_type":"newswire_release","title":"GenSight Biologics Announces Regulatory Approval for GS010/LUMEVOQ® REVISE Dose-Ranging Study in France","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251202055055/en/GenSight-Biologics-Announces-Regulatory-Approval-for-GS010LUMEVOQ-REVISE-Dose-Ranging-Study-in-France","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SOpuZ2eDr2-qrTzhotIWeMyRwQ9f9WKq4uzGzaY6op--5J1p5FUxZquwOuJanhBQsTnE93H1te7jN8305ie5AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-11-13","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1915","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1915","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DQj0TaJUxgbn3Ua2mXx-CGy80eSjAlsDuHvrr8v2mDMpTpyits8J3zDT9zkbQDpXRbT5ErxAQUlepDF1F8oeCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-11-09","event_type":"newswire_release","title":"GenSight Biologics Announces Successful Fundraising Amounting to Nearly €2 Million","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251109771235/en/GenSight-Biologics-Announces-Successful-Fundraising-Amounting-to-Nearly-%E2%82%AC2-Million","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3QNX6aJHKZQDrnmCtLVM2pLt5nnpSMqEtdqZPQDmyrZgVQayhkBqik3vCwXq5SXXGBWfd4oIT5yYQU4XtxCkCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-11-09","event_type":"newswire_release","title":"GenSight Biologics Announces Successful Fundraising Amounting to Nearly €2 Million","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251109771235/en/GenSight-Biologics-Announces-Successful-Fundraising-Amounting-to-Nearly-€2-Million","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"USgOuxpmf0seySzV6COUtXSTGB_51Wna4eNu0NScG3cx45XISm0X6j1J9DrQtidMq1fDkeHC4NSAPASSl_7bAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-11-06","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1875","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1875","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer GENSIGHT BIOLOGICS S.A.","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qDafXoU8SCjyTrMi24yzvZiSbpz4zHKcRDls7qO0dPLmkfjhF_LcbNOAZqUJUrqSce1eBPqyErU9toKyzeurAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-10-30","event_type":"newswire_release","title":"GenSight Biologics Announces Regulatory Authorizations for ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251029196714/en/GenSight-Biologics-Announces-Regulatory-Authorizations-for-Individual-Patient-Expanded-Access-Treatment-with-GS010LUMEVOQ-in-the-US","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iVriVI4Qg79M0QbzlC4YAbSyZvULkcw7fQ5bJk8jc5KRpkH4qe19BrKqs6QPAAvlNzbXEZ33F_X1jt97IEcNDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0013183985","date":"2025-10-07","event_type":"newswire_release","title":"GenSight Biologics Reports Cash Position as of September 30, 2025","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251007011599/en/GenSight-Biologics-Reports-Cash-Position-as-of-September-30-2025","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"a1hYZvG7-p7kzalgl1EcLSBwj7OxiGrdZAR-Z0UQcOeAdlmukhI6V8reQpH6n5wE8917P0SDqtZPrd-5mR8XDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}